Literature DB >> 32162173

Morphologic description of male reproductive accessory glands in a mouse model of mucopolysaccharidosis type I (MPS I).

Cinthia Castro do Nascimento1,2, Odair Aguiar Junior2, Vânia D'Almeida3.   

Abstract

Mucopolysaccharidosis type I (MPS I) is a genetic disease caused by a deficiency of the lysosomal hydrolase α-L-iduronidase (IDUA). IDUA degrades two types of glycosaminoglycans (GAGs): heparan and dermatan sulfates, important components of extracellular matrix, with signaling and structural functions. The accumulation of GAGs results in progressive physiological impairments in a variety of tissues, making MPS I a complex and multisystemic disease. Due the advent of therapeutic strategies which have increased patients' life expectancy, our group have been investigating the effect of IDUA deficiency on the reproductive system. In the present study, we aimed to characterize some of the accessory glands of the male reproductive tract in an MPS I mouse model. We used 6-month-old Idua+/+ and Idua-/- male mice to evaluate the histology of the seminal vesicles and prostate. Interstitial deposits of GAGs and collagen fibers were also observed. Seminal vesicles were smaller in the Idua-/- group, regardless of the normal staining pattern of the epithelial cells, marked with antiandrogen receptor. The prostate of Idua-/- mice presented necrotic acini and increased deposition of collagen fibers in the interstitium. All glands presented evident deposits of GAGs in the extracellular matrix, especially inside vacuolated interstitial cells. We concluded that, at this stage of the disease, the prostate is the most damaged accessory gland and may therefore, be the first to manifest functional impairments during disease progression.

Entities:  

Keywords:  Glycosaminoglycans; Mice; Mucopolysaccharidosis; Prostate; Seminal vesicles

Mesh:

Substances:

Year:  2020        PMID: 32162173     DOI: 10.1007/s10735-020-09864-x

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  20 in total

1.  Successful pregnancy and breastfeeding in a woman with mucopolysaccharidosis type I while receiving laronidase enzyme replacement. therapy.

Authors:  M Castorina; D Antuzzi; S M Richards; G F Cox; Y Xue
Journal:  Clin Exp Obstet Gynecol       Date:  2015       Impact factor: 0.146

2.  Enzyme-replacement therapy in mucopolysaccharidosis I.

Authors:  E D Kakkis; J Muenzer; G E Tiller; L Waber; J Belmont; M Passage; B Izykowski; J Phillips; R Doroshow; I Walot; R Hoft; E F Neufeld
Journal:  N Engl J Med       Date:  2001-01-18       Impact factor: 91.245

3.  Enzyme replacement therapy improves reproductive performance in mucopolysaccharidosis type VII mice but does not prevent postnatal losses.

Authors:  B W Soper; A W Pung; C A Vogler; J H Grubb; W S Sly; J E Barker
Journal:  Pediatr Res       Date:  1999-02       Impact factor: 3.756

4.  Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB.

Authors:  Kazuhiro Ohmi; David S Greenberg; Kavitha S Rajavel; Sergey Ryazantsev; Hong Hua Li; Elizabeth F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-07       Impact factor: 11.205

5.  Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation.

Authors:  Dan Wang; Charu Shukla; Xiaoli Liu; Trenton R Schoeb; Lorne A Clarke; David M Bedwell; Kim M Keeling
Journal:  Mol Genet Metab       Date:  2010-01       Impact factor: 4.797

6.  Mucopolysaccharidosis I: management and treatment guidelines.

Authors:  Joseph Muenzer; James E Wraith; Lorne A Clarke
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

7.  Fixation of testes and eyes using a modified Davidson's fluid: comparison with Bouin's fluid and conventional Davidson's fluid.

Authors:  John R Latendresse; Alan R Warbrittion; Henning Jonassen; Dianne M Creasy
Journal:  Toxicol Pathol       Date:  2002 Jul-Aug       Impact factor: 1.902

8.  Effects of experimental diabetes on the structure and ultrastructure of the coagulating gland of C57BL/6J and NOD mice.

Authors:  C A F Carvalho; A M Camargo; V H A Cagnon; C R Padovani
Journal:  Anat Rec A Discov Mol Cell Evol Biol       Date:  2003-02

9.  Decreased performance in IDUA knockout mouse mimic limitations of joint function and locomotion in patients with Hurler syndrome.

Authors:  Chihwa Kim; Min Jung Kwak; Sung Yoon Cho; Ah-Ra Ko; Jinguen Rheey; Jeong-Yi Kwon; Yokyung Chung; Dong-Kyu Jin
Journal:  Orphanet J Rare Dis       Date:  2015-09-25       Impact factor: 4.123

10.  Pregnancy in patients with mucopolysaccharidosis: a case series.

Authors:  Fiona J Stewart; Andrew Bentley; Barbara K Burton; Nathalie Guffon; Susan L Hale; Paul R Harmatz; Susanne G Kircher; Pavan K Kochhar; John J Mitchell; Ursula Plöckinger; Sue Graham; Stephen Sande; Zlatko Sisic; Tracey A Johnston
Journal:  Mol Genet Metab Rep       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.